Publication2023
Refractory alopecia in lupus treated with tofacitinib — a case-based review
The record
- Type
- Publication
- Date
- 1 August 2023
- Level
- National
- Journal
- Clinical Rheumatology
- Volume
- 42
- Issue
- 8
- Pages
- 2237-2241
- Published
- 1 August 2023
- DOI
- 10.1007/s10067-023-06632-6
- Scopus ID
- 85159333297
- ISSN
- 07703198
- Authors
- 6
- Open access
- No
- Citations
- 5
- International co-authorship
- No
- Co-author countries
- IN
Classification
Every label below carries the reasoning it was assigned on, the confidence band it was assigned in, and what produced it. The rubric is published.
UN Sustainable Development Goals
3.8 Achieve universal health coverage, including financial risk protection and access to essential medicines
Tofacitinib JAK inhibitor treatment demonstrates efficacy for refractory alopecia in systemic lupus erythematosus with sustained regrowth.
- Moderate confidence
- The alignment is plausible and defensible but rests on an assumption a reasonable reviewer could decline. Published, and surfaced in the review queue for a human to confirm or override.
- Judged
- Judged against the published classification rubric, under the rubric and prompt versions recorded with the run that produced it.
- Produced by
- claude-haiku-4-5-20251001, under kortex-publication-v1
5 Achieve gender equality and empower all women and girls
Improved treatment outcomes for SLE particularly affects women who comprise majority of lupus patients reducing psychosocial burden.
- Produced by
- claude-haiku-4-5-20251001, under kortex-publication-v1
Viksit Bharat @2047
vb-1.2 Health and well-being
Therapeutic advances in autoimmune disease management improve health and well-being for women with systemic lupus erythematosus.
- Produced by
- claude-haiku-4-5-20251001, under kortex-publication-v1
Each label above carries the instrument and the version that produced it. How each classification is reached.
Evidence
Kortex hosts no documents. Evidence is an outbound link to the authority that holds it.
No outbound evidence link is recorded for this activity. The record below states which source it came from and when it was last read.
Provenance
Which source system this record came from, how many source rows were resolved into it, and when each was last read.
- Source rows resolved into this record
- 1
Each record carries the date Kortex last read it from its source system. That is a freshness date and not a verification: Kortex records what its sources say and when it read them, and it does not check those statements against any external authority. No claim on this site is described as verified, because none is.
Citing this record
This URL is stable. A record’s permalink is frozen when it is published and is not regenerated if its title is later corrected.
KIIT Deemed to be University. “Refractory alopecia in lupus treated with tofacitinib — a case-based review”. Kortex.